HHSN272201800011I IDT biologika master cell banks manufacturing for next generation sars-COV-2 vaccines
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,623,000
Award facts
- Contract value 28% obligated
-
- $2,623,000.00 Current, with exercised options
- $9,317,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Exercise an Option | $1,678,100 | |
| Original award | $944,900 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract, valued at $9,317,000.00, is for the manufacturing of master cell banks for next-generation SARS-CoV-2 vaccines as part of pandemic preparedness efforts. The contract is a delivery order with a firm fixed-price pricing structure and has an ultimate completion date of April 18, 2025. IDT Biologika GMBH is a foreign-owned, for-profit organization that specializes in contract manufacturing of vaccines, viral vectors, and other biologics. This award is not associated with a set-aside designation.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 15, 2018.
How much is contract 75N93024F00001 worth?
The government has obligated $2,623,000 on 75N93024F00001. Its potential value, with all options, is $9,317,000.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award